SS+IPR+Neg+-+Buy+Drugs+CP

Generics are still too expensive for most African countries to purchase
Peggy B. **Sherman**, Assistant Professor of Legal Studies at Georgia State University, **and** Ellwood F. **Oakley**, III, Associate Professor of Legal Studies at Georgia State University, **2004** [“Pandemics and Panaceas: The World Trade Organization's Efforts to Balance Pharmaceutical Patents and Access to AIDS Drugs,” American Business Law Journal, 41 Am. Bus. L.J. 353, Winter/Spring, Lexis] Rein

__Most African countries have budgets too small and health systems too weak to take advantage of the availability of inexpensive drugs, even at__ Cipla's __discounted rates__. 204 Cipla's __generic AIDS drugs, despite their significantly lower price, have sold very poorly__. Venkat Kamalakar, general manager of international operations for Aurobindo, another Indian generic drug manufacturer, has likewise stated that __the "rock-bottom prices" charged by Aurobindo are too expensive for most African countries__. 205 __Legal debates over compulsory licensing and parallel importing are of minimal use to many African countries too poor to afford anti-AIDS drugs at any price__.